Cargando…
PB2424: ORAL VERSUS INTRAVENOUS ANTI-CMV PREEMPTIVE THERAPY IN ALLOGENEIC STEM CELL TRANSPLANT PATIENTS WITH CMV REACTIVATION: EXPERIENCE FROM NATIONAL CENTER OF BONE MARROW TRANSPLANTATION, TUNISIA.
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429059/ http://dx.doi.org/10.1097/01.HS9.0000976404.38888.d8 |
_version_ | 1785090620477407232 |
---|---|
author | Yosra Kanoun, Rimmel Ben Adejlil, Nour Rabeb, Jaied Hsasna, Roua Siwar, Frigui Mekni, Sabrine Torjemane, Lamia Turki, Ines Belloumi, Dorra Rihab, Ouerghi Yaiche, Insaf Ben Wafa, Achour Saloua, Ladeb Ben Othman, Tarek |
author_facet | Yosra Kanoun, Rimmel Ben Adejlil, Nour Rabeb, Jaied Hsasna, Roua Siwar, Frigui Mekni, Sabrine Torjemane, Lamia Turki, Ines Belloumi, Dorra Rihab, Ouerghi Yaiche, Insaf Ben Wafa, Achour Saloua, Ladeb Ben Othman, Tarek |
author_sort | Yosra Kanoun, Rimmel |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10429059 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104290592023-08-17 PB2424: ORAL VERSUS INTRAVENOUS ANTI-CMV PREEMPTIVE THERAPY IN ALLOGENEIC STEM CELL TRANSPLANT PATIENTS WITH CMV REACTIVATION: EXPERIENCE FROM NATIONAL CENTER OF BONE MARROW TRANSPLANTATION, TUNISIA. Yosra Kanoun, Rimmel Ben Adejlil, Nour Rabeb, Jaied Hsasna, Roua Siwar, Frigui Mekni, Sabrine Torjemane, Lamia Turki, Ines Belloumi, Dorra Rihab, Ouerghi Yaiche, Insaf Ben Wafa, Achour Saloua, Ladeb Ben Othman, Tarek Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429059/ http://dx.doi.org/10.1097/01.HS9.0000976404.38888.d8 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Publication Only Yosra Kanoun, Rimmel Ben Adejlil, Nour Rabeb, Jaied Hsasna, Roua Siwar, Frigui Mekni, Sabrine Torjemane, Lamia Turki, Ines Belloumi, Dorra Rihab, Ouerghi Yaiche, Insaf Ben Wafa, Achour Saloua, Ladeb Ben Othman, Tarek PB2424: ORAL VERSUS INTRAVENOUS ANTI-CMV PREEMPTIVE THERAPY IN ALLOGENEIC STEM CELL TRANSPLANT PATIENTS WITH CMV REACTIVATION: EXPERIENCE FROM NATIONAL CENTER OF BONE MARROW TRANSPLANTATION, TUNISIA. |
title | PB2424: ORAL VERSUS INTRAVENOUS ANTI-CMV PREEMPTIVE THERAPY IN ALLOGENEIC STEM CELL TRANSPLANT PATIENTS WITH CMV REACTIVATION: EXPERIENCE FROM NATIONAL CENTER OF BONE MARROW TRANSPLANTATION, TUNISIA. |
title_full | PB2424: ORAL VERSUS INTRAVENOUS ANTI-CMV PREEMPTIVE THERAPY IN ALLOGENEIC STEM CELL TRANSPLANT PATIENTS WITH CMV REACTIVATION: EXPERIENCE FROM NATIONAL CENTER OF BONE MARROW TRANSPLANTATION, TUNISIA. |
title_fullStr | PB2424: ORAL VERSUS INTRAVENOUS ANTI-CMV PREEMPTIVE THERAPY IN ALLOGENEIC STEM CELL TRANSPLANT PATIENTS WITH CMV REACTIVATION: EXPERIENCE FROM NATIONAL CENTER OF BONE MARROW TRANSPLANTATION, TUNISIA. |
title_full_unstemmed | PB2424: ORAL VERSUS INTRAVENOUS ANTI-CMV PREEMPTIVE THERAPY IN ALLOGENEIC STEM CELL TRANSPLANT PATIENTS WITH CMV REACTIVATION: EXPERIENCE FROM NATIONAL CENTER OF BONE MARROW TRANSPLANTATION, TUNISIA. |
title_short | PB2424: ORAL VERSUS INTRAVENOUS ANTI-CMV PREEMPTIVE THERAPY IN ALLOGENEIC STEM CELL TRANSPLANT PATIENTS WITH CMV REACTIVATION: EXPERIENCE FROM NATIONAL CENTER OF BONE MARROW TRANSPLANTATION, TUNISIA. |
title_sort | pb2424: oral versus intravenous anti-cmv preemptive therapy in allogeneic stem cell transplant patients with cmv reactivation: experience from national center of bone marrow transplantation, tunisia. |
topic | Publication Only |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429059/ http://dx.doi.org/10.1097/01.HS9.0000976404.38888.d8 |
work_keys_str_mv | AT yosrakanounrimmel pb2424oralversusintravenousanticmvpreemptivetherapyinallogeneicstemcelltransplantpatientswithcmvreactivationexperiencefromnationalcenterofbonemarrowtransplantationtunisia AT benadejlilnour pb2424oralversusintravenousanticmvpreemptivetherapyinallogeneicstemcelltransplantpatientswithcmvreactivationexperiencefromnationalcenterofbonemarrowtransplantationtunisia AT rabebjaied pb2424oralversusintravenousanticmvpreemptivetherapyinallogeneicstemcelltransplantpatientswithcmvreactivationexperiencefromnationalcenterofbonemarrowtransplantationtunisia AT hsasnaroua pb2424oralversusintravenousanticmvpreemptivetherapyinallogeneicstemcelltransplantpatientswithcmvreactivationexperiencefromnationalcenterofbonemarrowtransplantationtunisia AT siwarfrigui pb2424oralversusintravenousanticmvpreemptivetherapyinallogeneicstemcelltransplantpatientswithcmvreactivationexperiencefromnationalcenterofbonemarrowtransplantationtunisia AT meknisabrine pb2424oralversusintravenousanticmvpreemptivetherapyinallogeneicstemcelltransplantpatientswithcmvreactivationexperiencefromnationalcenterofbonemarrowtransplantationtunisia AT torjemanelamia pb2424oralversusintravenousanticmvpreemptivetherapyinallogeneicstemcelltransplantpatientswithcmvreactivationexperiencefromnationalcenterofbonemarrowtransplantationtunisia AT turkiines pb2424oralversusintravenousanticmvpreemptivetherapyinallogeneicstemcelltransplantpatientswithcmvreactivationexperiencefromnationalcenterofbonemarrowtransplantationtunisia AT belloumidorra pb2424oralversusintravenousanticmvpreemptivetherapyinallogeneicstemcelltransplantpatientswithcmvreactivationexperiencefromnationalcenterofbonemarrowtransplantationtunisia AT rihabouerghi pb2424oralversusintravenousanticmvpreemptivetherapyinallogeneicstemcelltransplantpatientswithcmvreactivationexperiencefromnationalcenterofbonemarrowtransplantationtunisia AT yaicheinsafben pb2424oralversusintravenousanticmvpreemptivetherapyinallogeneicstemcelltransplantpatientswithcmvreactivationexperiencefromnationalcenterofbonemarrowtransplantationtunisia AT wafaachour pb2424oralversusintravenousanticmvpreemptivetherapyinallogeneicstemcelltransplantpatientswithcmvreactivationexperiencefromnationalcenterofbonemarrowtransplantationtunisia AT saloualadeb pb2424oralversusintravenousanticmvpreemptivetherapyinallogeneicstemcelltransplantpatientswithcmvreactivationexperiencefromnationalcenterofbonemarrowtransplantationtunisia AT benothmantarek pb2424oralversusintravenousanticmvpreemptivetherapyinallogeneicstemcelltransplantpatientswithcmvreactivationexperiencefromnationalcenterofbonemarrowtransplantationtunisia |